Literature DB >> 32602268

Body mass index and the risk of COVID-19 across ethnic groups: Analysis of UK Biobank.

Cameron Razieh1,2, Francesco Zaccardi1,3, Melanie J Davies1,2,4, Kamlesh Khunti1,3,4,5, Thomas Yates1,2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32602268      PMCID: PMC7362044          DOI: 10.1111/dom.14125

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.408


× No keyword cloud information.
To the Editor: Coronavirus disease‐2019 (COVID‐19), an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2 virus), has devastated global economies and put unprecedented strain on clinical services. Emerging evidence has suggested that black and minority ethnic (BME) groups, particularly South Asian (SA) and black African or Caribbean (BAC) populations, are at an increased risk of COVID‐19 and resulting complications. Obesity is also associated with a higher risk of testing positive for, and dying from, COVID‐19. , However, the interaction between ethnicity and obesity on the risk of COVID‐19 has not been tested. As ethnicity is known to modify the association between body mass index (BMI) and cardiometabolic health, , we hypothesise that BMI also acts to modify the relative risk of COVID‐19 across ethnic groups. We used UK Biobank, a large prospective cohort of 502 543 individuals with baseline assessments conducted from March 2006 to July 2010. UK Biobank data were linked to national COVID‐19 laboratory test data through Public Health England. Data were available for the period from 16 March to 14 June 2020. We undertook an adjusted logistic regression to (a) quantify the association of BMI with the risk of a positive test for COVID‐19, stratified by ethnic group, and (b) investigate whether the odds of COVID‐19 in BME (SA and BAC) individuals relative to white Europeans (WEs) varied by BMI level. Non‐linear interactions were investigated using restricted cubic splines with knots placed at the 33th and 66th centile of BMI distribution. Models were adjusted for potential confounders (Figure 1) and the interaction was formally assessed using the likelihood ratio test.
FIGURE 1

Association of body mass index (BMI) with confirmed COVID‐19 in white European (WE) and black and minority ethnic (BME) individuals. Odds ratio (OR) for COVID‐19 with BMI stratified by BME and WE groups (left) and in BME relative to WE (right). Reference (OR 1) were placed at BMI of 25 kg/m2. OR (lines) and confidence intervals (CI; areas) are plotted across continuous BMI values (x axes) between the 2.5th (20 kg/m2) and 97.5th (39 kg/m2) centile of the distribution. Shaded area as 95% CI. Analysis adjusted for: age at test, sex, social deprivation (Townsend score), smoking status, cancer illnesses (number) and non‐cancer illnesses (number), systolic blood pressure, HDL‐cholesterol, total cholesterol and HbA1c

Association of body mass index (BMI) with confirmed COVID‐19 in white European (WE) and black and minority ethnic (BME) individuals. Odds ratio (OR) for COVID‐19 with BMI stratified by BME and WE groups (left) and in BME relative to WE (right). Reference (OR 1) were placed at BMI of 25 kg/m2. OR (lines) and confidence intervals (CI; areas) are plotted across continuous BMI values (x axes) between the 2.5th (20 kg/m2) and 97.5th (39 kg/m2) centile of the distribution. Shaded area as 95% CI. Analysis adjusted for: age at test, sex, social deprivation (Townsend score), smoking status, cancer illnesses (number) and non‐cancer illnesses (number), systolic blood pressure, HDL‐cholesterol, total cholesterol and HbA1c There were 5623 unique test results available (WE: 5352; BME: 271), of which 1087 (19.3%) were positive (WE: 1000 [18.7%]; BME: 87 [32.1%]). WE individuals with test data had a median (IQR) age of 71.3 (62.3, 76.1) years, a BMI of 27.6 (24.8, 30.9) kg/m2 and 2650 (49.5%) were women. Comparatively, BME individuals were 64.8 (57.9, 73.2) years old, had a BMI of 28.2 (25.2, 33.1) kg/m2 and 136 (50.2%) were women. The majority of the BME population (83%) were first‐generation migrants to the UK. BMI was associated with the risk of a positive test for COVID‐19 in both BME and WE individuals. However, the dose response association differed by ethnic group (P for interaction = .05) (Figure 1): in WE individuals, there was no additional higher risk of COVID‐19 beyond a BMI of 25 kg/m2, whereas in BME individuals the risk was greater for higher BMI values. Greater risk of COVID‐19 in BME individuals relative to WEs was only apparent at higher BMI values (Figure 1). For example, at a BMI value of 25 kg/m2, there was no difference in risk (OR = 0.96; 95% CI: 0.61, 1.52), whereas at a BMI of 30 or 35 kg/m2, the odds of COVID‐19 were 1.75 (1.24, 2.48) and 2.56 (1.63, 4.03) higher in BME individuals relative to WEs, respectively. Although limited by non‐random testing for COVID‐19 within the UK, these data suggest that the association between BMI and the risk of COVID‐19 may vary by ethnicity and act as an important effect modifier for the increased risk of COVID‐19 in BME populations. These results suggest that the combination of obesity and BME status may place individuals at a particularly high risk of contracting COVID‐19, consistent with findings for associations of BMI and ethnicity with cardiometabolic dysfunction. ,

CONFLICT OF INTEREST

None declared.

FUNDING INFORMATION

This work was supported by the NIHR Leicester Biomedical Research Centre.

AUTHOR CONTRIBUTIONS

Concept and design: C.R., T.Y. and K.K. Acquisition, analysis or interpretation of data: all authors. Drafting of the manuscript: C.R. and T.Y. Critical revision of the manuscript for important intellectual content: all authors. Statistical analysis: C.R. and T.Y. Statistical oversight: F.Z. Note that K.K. and T.Y. are joint senior authors.
  6 in total

1.  Ethnic differences in the relationships between obesity and glucose-metabolic abnormalities: a cross-sectional population-based study.

Authors:  F Razak; S Anand; V Vuksan; B Davis; R Jacobs; K K Teo; S Yusuf
Journal:  Int J Obes (Lond)       Date:  2005-06       Impact factor: 5.095

2.  Deriving ethnic-specific BMI cutoff points for assessing diabetes risk.

Authors:  Maria Chiu; Peter C Austin; Douglas G Manuel; Baiju R Shah; Jack V Tu
Journal:  Diabetes Care       Date:  2011-06-16       Impact factor: 19.112

3.  UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age.

Authors:  Cathie Sudlow; John Gallacher; Naomi Allen; Valerie Beral; Paul Burton; John Danesh; Paul Downey; Paul Elliott; Jane Green; Martin Landray; Bette Liu; Paul Matthews; Giok Ong; Jill Pell; Alan Silman; Alan Young; Tim Sprosen; Tim Peakman; Rory Collins
Journal:  PLoS Med       Date:  2015-03-31       Impact factor: 11.069

4.  Dynamic linkage of COVID-19 test results between Public Health England's Second Generation Surveillance System and UK Biobank.

Authors:  Jacob Armstrong; Justine K Rudkin; Naomi Allen; Derrick W Crook; Daniel J Wilson; David H Wyllie; Anne Marie O'Connell
Journal:  Microb Genom       Date:  2020-07

5.  Obesity and risk of COVID-19: analysis of UK biobank.

Authors:  Thomas Yates; Cameron Razieh; Francesco Zaccardi; Melanie J Davies; Kamlesh Khunti
Journal:  Prim Care Diabetes       Date:  2020-05-28       Impact factor: 2.459

6.  Factors associated with COVID-19-related death using OpenSAFELY.

Authors:  Elizabeth J Williamson; Alex J Walker; Krishnan Bhaskaran; Seb Bacon; Chris Bates; Caroline E Morton; Helen J Curtis; Amir Mehrkar; David Evans; Peter Inglesby; Jonathan Cockburn; Helen I McDonald; Brian MacKenna; Laurie Tomlinson; Ian J Douglas; Christopher T Rentsch; Rohini Mathur; Angel Y S Wong; Richard Grieve; David Harrison; Harriet Forbes; Anna Schultze; Richard Croker; John Parry; Frank Hester; Sam Harper; Rafael Perera; Stephen J W Evans; Liam Smeeth; Ben Goldacre
Journal:  Nature       Date:  2020-07-08       Impact factor: 49.962

  6 in total
  11 in total

1.  Sarcopenic obesity and the risk of hospitalization or death from coronavirus disease 2019: findings from UK Biobank.

Authors:  Thomas J Wilkinson; Thomas Yates; Luke A Baker; Francesco Zaccardi; Alice C Smith
Journal:  JCSM Rapid Commun       Date:  2021-07-03

2.  Leptin Deficiency, Caused by Malnutrition, Makes You Susceptible to SARS-CoV-2 Infection but Could Offer Protection from Severe COVID-19.

Authors:  Dewald Schoeman; Burtram C Fielding
Journal:  mSphere       Date:  2021-05-12       Impact factor: 4.389

3.  Modifiable and non-modifiable risk factors for COVID-19, and comparison to risk factors for influenza and pneumonia: results from a UK Biobank prospective cohort study.

Authors:  Frederick K Ho; Carlos A Celis-Morales; Stuart R Gray; S Vittal Katikireddi; Claire L Niedzwiedz; Claire Hastie; Lyn D Ferguson; Colin Berry; Daniel F Mackay; Jason Mr Gill; Jill P Pell; Naveed Sattar; Paul Welsh
Journal:  BMJ Open       Date:  2020-11-19       Impact factor: 3.006

4.  Obesity, Ethnicity, and Risk of Critical Care, Mechanical Ventilation, and Mortality in Patients Admitted to Hospital with COVID-19: Analysis of the ISARIC CCP-UK Cohort.

Authors:  Thomas Yates; Francesco Zaccardi; Nazrul Islam; Cameron Razieh; Clare L Gillies; Claire A Lawson; Yogini Chudasama; Alex Rowlands; Melanie J Davies; Annemarie B Docherty; Peter J M Openshaw; J Kenneth Baillie; Malcolm G Semple; Kamlesh Khunti
Journal:  Obesity (Silver Spring)       Date:  2021-05-14       Impact factor: 9.298

5.  Lung Function Levels Influence the Association between Obesity and Risk of COVID-19.

Authors:  Dinh S Bui; Raisa Cassim; Melissa A Russell; Alice Doherty; Adrian J Lowe; Alvar Agusti; Shyamali C Dharmage; Caroline J Lodge
Journal:  Am J Respir Crit Care Med       Date:  2021-11-01       Impact factor: 21.405

6.  Health behaviour change during the UK COVID-19 lockdown: Findings from the first wave of the C-19 health behaviour and well-being daily tracker study.

Authors:  Felix Naughton; Emma Ward; Mizanur Khondoker; Pippa Belderson; Anne Marie Minihane; Jack Dainty; Sarah Hanson; Richard Holland; Tracey Brown; Caitlin Notley
Journal:  Br J Health Psychol       Date:  2021-01-06

7.  Obese COVID-19 patients show more severe pneumonia lesions on CT chest imaging.

Authors:  Xiao Luo; Yeerfan Jiaerken; Zhujing Shen; Qiyuan Wang; Bo Liu; Haisheng Zhou; Hanpeng Zheng; Yongchou Li; Yuantong Gao; Susu He; Wenbin Ji; Yongqiang Liu; Jianbing Ma; Longyun Mao; Xiangming Wang; Meihao Wang; Miaoguang Su; Peiyu Huang; Lei Shi; Minming Zhang
Journal:  Diabetes Obes Metab       Date:  2020-11-19       Impact factor: 6.408

8.  Obesity as a driver of international differences in COVID-19 death rates.

Authors:  Julian Gardiner; Jude Oben; Alastair Sutcliffe
Journal:  Diabetes Obes Metab       Date:  2021-03-15       Impact factor: 6.408

9.  Case-control study of the association of chronic acid suppression and social determinants of health with COVID-19 infection.

Authors:  Bing Zhang; Anna L Silverman; Saroja Bangaru; Douglas Arneson; Sonya Dasharathy; Nghia Nguyen; Diane Rodden; Jonathan Shih; Atul J Butte; Wael Noor El-Nachef; Brigid S Boland; Vivek Ashok Rudrapatna
Journal:  Sci Rep       Date:  2021-10-25       Impact factor: 4.379

10.  A population-based cohort study of obesity, ethnicity and COVID-19 mortality in 12.6 million adults in England.

Authors:  Kamlesh Khunti; Vahé Nafilyan; Thomas Yates; Annabel Summerfield; Cameron Razieh; Amitava Banerjee; Yogini Chudasama; Melanie J Davies; Clare Gillies; Nazrul Islam; Claire Lawson; Evgeny Mirkes; Francesco Zaccardi
Journal:  Nat Commun       Date:  2022-02-02       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.